Results 41 to 50 of about 347,568 (271)

Developmentally appropriate transitional care during the Covid-19 pandemic for young people with juvenile-onset rheumatic and musculoskeletal diseases: the rationale for a position statement

Pediatric Rheumatology Online Journal, 2021
Background The importance of developmentally appropriate transitional care in young people with juvenile-onset rheumatic and musculoskeletal disease is well recognised.
Janet E. McDonagh, Rachel Tattersall, Jacqui Clinch, Joanne Swan, Helen E. Foster, Liza McCann   +5 more
doaj   +1 more source

Expansion of a novel population of NK cells with low ribosome expression in juvenile dermatomyositis

Frontiers in Immunology, 2022
Juvenile dermatomyositis (JDM) is a pediatric autoimmune disease associated with characteristic rash and proximal muscle weakness. To gain insight into differential lymphocyte gene expression in JDM, peripheral blood mononuclear cells from 4 new-onset ...
K. Hilliard, Allison A. Throm, J. Pingel, Nermina Saucier, H. Zaher, A. French   +5 more
semanticscholar   +1 more source

A Cause of High Creatine Kinase: A Case of Juvenile Dermatomyositis

Haseki Tıp Bülteni, 2014
Although juvenile dermatomyositis is rare, it is the most common idiopathic nonsupurrative inflammatory myositis in childhood. Skin lesions, proximal muscle weakness, elevated levels of muscle enzymes, electromyography, and muscle biopsy findings are ...
İsmail Yıldız, Özge Umur, Muhammet Ali Varkal, Alev Yılmaz, Gökçen Gündoğdu, Ayşe Kılıç, Fatma Oğuz, Emin Ünüvar   +7 more
doaj   +1 more source

Adult and juvenile dermatomyositis treatment

Journal of Cosmetic Dermatology, 2022
Dermatomyositis is a rare autoimmune inflammatory condition affecting skin and muscles. The disease can be seen in both adults and children. It can be associated with malignancy.
Anant D Patil, Jun Lu, M. Kassir, Mahsa Babaei, M. Goldust   +4 more
semanticscholar   +1 more source

Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease. [PDF]

, 2013
OBJECTIVES: To study muscle biopsy tissue from patients with juvenile dermatomyositis (JDM) in order to test the reliability of a score tool designed to quantify the severity of histological abnormalities when applied to biceps humeri in addition to ...
Amato, Anthony A, Banwell, Brenda, Bove, Kevin E, Charman, Susan C, Corse, Andrea M, Emslie-Smith, Alison M, Holton, Janice L, Jacques, Thomas S, Li, Charles K, Lundberg, Ingrid E, Marie, Suely KN, Minetti, Carlo, Nennesmo, Inger, Pilkington, Clarissa A, Rushing, Elisabeth J, Sallum, Adriana ME, Sewry, Caroline, UK Juvenile Dermatomyositis Research Group, Varsani, Hemlata, Wedderburn, Lucy R   +19 more
core   +3 more sources

Skeletal muscle major histocompatibility complex class I and II expression differences in adult and juvenile dermatomyositis

Clinics, 2012
OBJECTIVE: To analyze major histocompatibility complex expression in the muscle fibers of juvenile and adult dermatomyositis. METHOD: In total, 28 untreated adult dermatomyositis patients, 28 juvenile dermatomyositis patients (Bohan and Peter's criteria)
Samuel Katsuyuki Shinjo, Adriana Maluf Elias Sallum, Clovis Artur Silva, Suely Kazue Nagahashi Marie   +3 more
doaj   +1 more source

Updates on interferon in juvenile dermatomyositis: pathogenesis and therapy

Current Opinion in Rheumatology, 2021
Purpose of review This review provides updates regarding the role of interferon (IFN) in juvenile dermatomyositis (JDM), including comparison to interferonopathies and therapeutic implications.
Hanna Kim
semanticscholar   +1 more source

The Vasculopathy of Juvenile Dermatomyositis: Endothelial Injury, Hypercoagulability, and Increased Arterial Stiffness

Arthritis & Rheumatology, 2021
Vasculopathy is considered central to the pathogenesis of juvenile dermatomyositis (DM) and is associated with severe extramuscular manifestations.
C. Papadopoulou, Ying Hong, P. Król, Muthana Al Obaidi, C. Pilkington, L. Wedderburn, P. Brogan, D. Eleftheriou   +7 more
semanticscholar   +1 more source

Nodular Regenerative Hyperplasia of the liver in Juvenile Dermatomyositis

Pediatric Rheumatology Online Journal, 2022
Background We present two cases of Nodular Regenerative Hyperplasia (NRH) associated with Juvenile Dermatomyositis (JDM). Case Presentation Case 1: A nine-year-old Caucasian male with refractory JDM and anti-NXP2 autoantibodies was diagnosed at age two ...
Aviya Lanis, Rita Volochayev, D. Kleiner, Anusha Vittal, T. Heller, L. Rider, S. Shenoi   +6 more
semanticscholar   +1 more source

Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis [PDF]

Rheumatology, 2018
We examined features of clinically amyopathic JDM (CAJDM), in which patients have characteristic rashes with little to no evidence of muscle involvement, to determine whether this is a distinct phenotype from JDM.Demographic, clinical, laboratory and treatment data from 12 (9 hypomyopathic, 3 amyopathic) patients meeting modified Sontheimer criteria ...
Gulnara Mamyrova, Takayuki Kishi, Ira N Targoff, Alison Ehrlich, Rodolfo V Curiel, Lisa G Rider, Leslie S Abramson, Bita Arabshahi, Victoria Cartwright, Elizabeth J Chalom, Barbara Anne Eberhardt, William Hannan, Gloria C Higgins, Robert C Fuhlbrigge, Jerry C Jacobs, Lawrence Jung, Yukiko Kimura, Carol B Lindsley, Alan L Martin, Frederick W Miller, Diana Milojevic, Barbara E Ostrov, Maria D Perez, Rafael F Rivas-Chacon, Margalit Rosenkranz, David D Sherry, Jennifer Soep, Sangeeta Sule, Scott A Vogelgesang   +28 more
openaire   +2 more sources